Biophan Technologies, Inc. was Issued Two New U.S. Patents Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biophan Technologies, Inc. was Issued Two New U.S. Patents

BIPH 16.60

+0.3%

Jan 9 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: siamese1	3/16/2005 11:56:16 AM
	of 10

Biophan Technologies, Inc today announced plans to begin animal trials of its advanced MRI-imageable vena cava filter, in a research underway at th Company's newly established Biophan-Europe division. The announcement of the trials, anticipated to commence within the next quarter, was made by Michael Weiner, Chief Executive Officer of Biophan. Vena Cava filters are used in the main venous system, where they remain either temporarily or permanently, to trap circulating blood clots, plaque, or other materials that can cause life threatening lung embolisms. The Company's vena cava filter was developed at its Biophan-Europe division, a German company formerly known as AMRIS GmbH. Biophan recently acquired a controlling interest in the company, which is recognized as a leading innovator of medical device and technology solutions compatible with Magnetic Resonance Imaging(MRI).

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next